Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1991-06-10
1992-09-08
Lee, Lester L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 6, 530330, 530331, A61K 3702, A61K 3714
Patent
active
051458381
ABSTRACT:
A variety of compositions suitable for use with methods for (a) reducing the formation of stomach ulcers in warm-blooded animals, (b) reducing the secretion of stomach acid in warm-blooded animals, (c) increasing the secretion of cytoprotective mucous in the stomach of warm-blooded animals, and (d) healing established stomach or intestinal ulcers in warm-blooded animals are disclosed. The compositions include glycyl-L-histidyl-L-lysine, L-lysyl-L-histidyl-glycine, L-lysyl-L-histidyl-glycine:copper (II), glycyl-L-histidyl-L-lysine:copper (II), and derivatives thereof.
REFERENCES:
patent: 3194732 (1965-07-01), Neuhauser
patent: 3551554 (1970-12-01), Herschler
patent: 3558770 (1971-01-01), Gordon et al.
patent: 3758682 (1973-09-01), Huber
patent: 3767784 (1973-10-01), Gluck
patent: 3832338 (1974-08-01), Huber et al.
patent: 4022888 (1977-05-01), Huber et al.
patent: 4167945 (1979-09-01), Gottlieb
patent: 4177261 (1979-12-01), Dietze et al.
patent: 4263428 (1981-04-01), Apple et al.
patent: 4287184 (1981-09-01), Young
patent: 4440788 (1984-04-01), Terayama et al.
patent: 4665054 (1987-05-01), Pickart
patent: 4760051 (1988-07-01), Pickart
patent: 5023237 (1991-06-01), Pickart
Pickart et al., "Growth-Modulating Tripeptide (glycylhistidyllysine): Association with Copper and Iron in Plasma and Stimulation of Adhesive and Growth of Hepatoma Cells in Culture by Tripeptide-Metal Ion Complexes," J. Physiol. 102(2):129-139, 1980.
Williams et al., "Glycyl-L-Histidyl-l-Lysine, a Growth Promoting Factor for Human Cells," Cytobios 27(105):19-25, 1980.
Mochida Pharmaceutical Co., Ltd., "Anti-Inflammatory Injections Containing Superoxide Dismutase," Jpn. Kokai Tokkyo Koho, 81 07,720,27 Jan. 1981 (cited in Chem. Abstracts 94:145386f, 1981).
Kwa, "Glycyl-L-Histidyl-L-Lysine: Synthesis of Analogs and NMR Studies," Ph. D. Thesis, University of Washington, 1983.
Loker, "Synthesis of Blood Serum Peptide Cell Growth Factors," Ph. D. Thesis, University of Washington, 1980.
Pickart, "The Biological Effects and Mechanism of Action of the Plasma Tripeptide Glycyl-L-Lysine," Lymphonkines 8:425-446, 1983.
Poole et al., "Stimulation of Rat Peritoneal Mast Cell Migration by Tumor-Derived Peptides," Cancer Research 43:5857-5861, 1983.
Raju et al., "Ceruloplasmin, Copper Ions, and Angiogenesis," JNCI 69(5):1183-1188, 1982.
Freedman et al., "Structure of the Glycyl-L-Histidyl-L-Lysine-Copper (II) Complex in Solution," Biochemistry 21:4540-4544, 1982.
Kwa et al., "PMR Studies of Cu(II) and Zn(II) Interaction with Glycyl-L-Histidyl-L-Lysine and Related Peptides," Peptides: Structure and Function 8:805-808, 1983.
Perkins et al., "The Structure of a Copper Complex of the Growth Factor Glycyl-L-Histidyl-L-Lysine at 1.1 A Resolution," Inorganica Chemica Acta 82:93-99, 1984.
Kimoto et al., "Enhancement of Antitumor Activity of Ascorbate Against Ehrlich Ascites Tumor Cells by the Copper: Glycylglycylhistidine Complex," Cancer Research 43:824-828, 1983.
Sorenson, "Copper Complexes: A Physiologic Approach to Treatment of Chronic Diseases," Comprehensive Therapy 11(4):49-64, 1985.
Pickart et al., "Inhibition of the Growth of Cultured Cells and an Implanted Fibrosarcoma by Aroylhydazone Analogs of the Gly-His-Lys-Cu(II) Complex," Biochem. Pharmacol. 32(24):3868-3871, 1983.
Pickart et al., "Growth-Modulating Plasma Tripeptide May Function By Facilitating Copper Uptake Into Cells," Nature 288:715-717, 1980.
"Newsreport on use of GGH-Cu(II) and Ascorbic Acid," Natural Healing Annual 1986, p. 38 (M. Bricklin (ed.), Prevention Magazine, Rodale Press, Emmaus, Pa.).
Pickart et al., "A Synthetic Tripeptide which Increases Survival of Normal Liver Cells, and Stimulates Growth in Hepatoma Cells," Biochem. Biophys. Res. Commun. 54(2):562-66, 1973.
Aonuma et al., "Studies on Anti-Ulcerogenic Protein in Inflamed Rabbit Skin Tissues," Yakugaku Zasshi 104(4):362-73, 1984.
Downey et al., "Acceleration of Wound Healing Using GHL-Cu(II)," Surgical Forum 36:573-75 (1985).
Pickart et al., "A Human Plasma Growth Factor with Superoxide Dismutase-like and Wound-healing Properties," Superoxide Dim. Chem., Biol. Med. Proc. Int. Conf. 4th 1985 (Pub. 1986), 555-57 (cited in Chem. Abstracts 106:13579c).
Frater-Schroeder et al., "Tumor Necrosis Factor Type .alpha., a Potential Inhibitor of Endothelial Cell Growth in vitro is Angiogenic in vivo," Proc. Natl. Acad. Sci. U.S.A. 34:5277-81 (1987).
Pickart, "The Use of Glycylhistidyllysine in Culture Systems," In Vitro 17(6):459-66 (1981).
Lee Lester L.
ProCyte Corporation
LandOfFree
Methods and compositions for healing ulcers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for healing ulcers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for healing ulcers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-134339